高血清维生素D浓度可能预防多发性硬化症。
High serum concentration of vitamin D may protect against multiple sclerosis.
作者信息
Biström Martin, Alonso-Magdalena Lucia, Andersen Oluf, Jons Daniel, Gunnarsson Martin, Vrethem Magnus, Hultdin Johan, Sundström Peter
机构信息
Department of Pharmacology and Clinical Neuroscience, Umeå University, Sweden.
Department of Neurology, Skåne University Hospital in Malmö/Lund and Institution of Clinical Sciences, Neurology, Lund University, Sweden.
出版信息
Mult Scler J Exp Transl Clin. 2019 Dec 6;5(4):2055217319892291. doi: 10.1177/2055217319892291. eCollection 2019 Oct-Dec.
Abstract
BACKGROUND
High 25-hydroxyvitamin D concentrations have been associated with a reduced risk of multiple sclerosis, with indications of a stronger effect among young individuals.
OBJECTIVE
Investigate the 25-hydroxyvitamin D association with multiple sclerosis and test if this association is age dependent.
METHODS
Prospectively drawn blood samples from individuals later developing relapsing-remitting multiple sclerosis and controls matched for biobank, sex, age and date of sampling, were analysed with liquid chromatography tandem mass spectrometry.
RESULTS
High levels of 25-hydroxyvitamin D (top quintile) were associated with a reduced multiple sclerosis risk (odds ratio 0.68, 95% confidence interval 0.50-0.93).
CONCLUSION
These findings further support a role for vitamin D in MS aetiology.
摘要
背景
25-羟基维生素D浓度较高与多发性硬化症风险降低有关，且有迹象表明在年轻人中这种作用更强。
目的
研究25-羟基维生素D与多发性硬化症的关联，并检验这种关联是否与年龄有关。
方法
采用液相色谱串联质谱法分析前瞻性采集的血液样本，这些样本来自后来发展为复发缓解型多发性硬化症的个体以及与生物样本库、性别、年龄和采样日期相匹配的对照组。
结果
25-羟基维生素D水平较高（最高五分位数）与多发性硬化症风险降低相关（比值比0.68，95%置信区间0.50 - 0.93）。
结论
这些发现进一步支持了维生素D在多发性硬化症病因学中的作用。
相似文献
1
High serum concentration of vitamin D may protect against multiple sclerosis.高血清维生素D浓度可能预防多发性硬化症。
Mult Scler J Exp Transl Clin. 2019 Dec 6;5(4):2055217319892291. doi: 10.1177/2055217319892291. eCollection 2019 Oct-Dec.
2
Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.新生儿维生素D状况与多发性硬化症风险：一项基于人群的病例对照研究。
Neurology. 2017 Jan 3;88(1):44-51. doi: 10.1212/WNL.0000000000003454. Epub 2016 Nov 30.
3
Association of seasonal serum 25-hydroxyvitamin D levels with disability and relapses in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症患者季节性血清25-羟基维生素D水平与残疾及复发的相关性
Eur J Clin Nutr. 2016 Sep;70(9):995-9. doi: 10.1038/ejcn.2016.51. Epub 2016 Mar 30.
4
Neonatal vitamin D status and risk of multiple sclerosis.新生儿维生素 D 状况与多发性硬化症风险。
Ann Neurol. 2014 Sep;76(3):338-46. doi: 10.1002/ana.24210. Epub 2014 Jul 10.
5
Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.前瞻性多发性硬化症生物库样本中的 Epstein-Barr 病毒抗体和维生素 D。
Mult Scler. 2013 Oct;19(12):1587-91. doi: 10.1177/1352458513483888. Epub 2013 Apr 2.
6
Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.维生素D与完全可走动的复发缓解型多发性硬化症患者的残疾程度相关。
Eur J Neurol. 2015 Mar;22(3):564-9. doi: 10.1111/ene.12617. Epub 2014 Dec 20.
7
Leptin levels are associated with multiple sclerosis risk.瘦素水平与多发性硬化症风险相关。
Mult Scler. 2021 Jan;27(1):19-27. doi: 10.1177/1352458520905033. Epub 2020 Feb 7.
8
Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study.新生儿维生素D状况与精神分裂症风险：一项基于人群的病例对照研究。
Arch Gen Psychiatry. 2010 Sep;67(9):889-94. doi: 10.1001/archgenpsychiatry.2010.110.
9
25-hydroxyvitamin D levels are associated with multiple sclerosis in Iran: A cross-sectional study.25-羟基维生素D水平与伊朗的多发性硬化症相关：一项横断面研究。
J Neuroimmunol. 2016 Jan 15;290:47-8. doi: 10.1016/j.jneuroim.2015.11.017. Epub 2015 Nov 29.
10
Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab.维生素 D 补充剂可降低那他珠单抗治疗的复发缓解型多发性硬化患者的复发率。
Mult Scler Relat Disord. 2016 Nov;10:169-173. doi: 10.1016/j.msard.2016.10.005. Epub 2016 Oct 26.
引用本文的文献
1
Potential pathogenic and protective genotypes and phenotypes of vitamin D binding protein in multiple sclerosis.维生素D结合蛋白在多发性硬化症中的潜在致病和保护基因型及表型
Front Neurol. 2025 Feb 7;16:1455779. doi: 10.3389/fneur.2025.1455779. eCollection 2025.
2
Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis.风疹病毒感染或接种疫苗后的血清阳性作为多发性硬化症的一个风险因素。
Eur J Neurol. 2024 Oct;31(10):e16387. doi: 10.1111/ene.16387. Epub 2024 Jul 18.
3
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.人类疱疹病毒 6A 与多发性硬化症临床发作前的轴索损伤。
Brain. 2024 Jan 4;147(1):177-185. doi: 10.1093/brain/awad374.
4
Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage.针对裂解、潜伏和可能交叉反应的 EBV 抗原的血清反应平均在 MS 引起临床前神经轴突损伤前 10 年出现。
J Neurol Neurosurg Psychiatry. 2024 Mar 13;95(4):325-332. doi: 10.1136/jnnp-2023-331868.
5
Systemic inflammation and risk of multiple sclerosis - A presymptomatic case-control study.全身炎症与多发性硬化症风险——一项症状前病例对照研究。
Mult Scler J Exp Transl Clin. 2022 Nov 22;8(4):20552173221139768. doi: 10.1177/20552173221139768. eCollection 2022 Oct-Dec.
6
Free vitamin D index and vitamin D-binding protein in multiple sclerosis: A presymptomatic case-control study.多发性硬化症患者的游离维生素 D 指数和维生素 D 结合蛋白：一项前瞻性病例对照研究。
Eur J Neurol. 2022 Aug;29(8):2335-2342. doi: 10.1111/ene.15407. Epub 2022 Jun 4.
7
Axonal injury in asymptomatic individuals preceding onset of multiple sclerosis.多发性硬化症发病前无症状个体的轴突损伤。
Ann Clin Transl Neurol. 2022 Jun;9(6):882-887. doi: 10.1002/acn3.51568. Epub 2022 May 3.
8
The Multiple Sclerosis Prodrome: Evidence to Action.多发性硬化前驱期：从证据到行动。
Front Neurol. 2022 Jan 31;12:761408. doi: 10.3389/fneur.2021.761408. eCollection 2021.
9
Uptake of Vitamins D, D, D, D, D, and D Solubilized in Mixed Micelles by Human Intestinal Cells, Caco-2, an Enhancing Effect of Lysophosphatidylcholine on the Cellular Uptake, and Estimation of Vitamins D' Biological Activities.混合胶束中维生素 D、D、D、D、D 和 D 的人肠细胞 Caco-2 摄取、溶血磷脂酰胆碱对细胞摄取的促进作用及维生素 D'生物活性的估算
Nutrients. 2021 Mar 29;13(4):1126. doi: 10.3390/nu13041126.
10
Does the High Prevalence of Vitamin D Deficiency in African Americans Contribute to Health Disparities?非裔美国人中维生素D缺乏的高流行率是否导致了健康差异？
Nutrients. 2021 Feb 3;13(2):499. doi: 10.3390/nu13020499.
本文引用的文献
1
Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality.膳食ω-6 脂肪酸生物标志物与心血管疾病和死亡事件的关系。
Circulation. 2019 May 21;139(21):2422-2436. doi: 10.1161/CIRCULATIONAHA.118.038908.
2
Vitamin D in individuals before onset of rheumatoid arthritis - relation to vitamin D binding protein and its associated genetic variants.类风湿关节炎发病前个体中的维生素D——与维生素D结合蛋白及其相关基因变异的关系
BMC Rheumatol. 2018 Sep 12;2:26. doi: 10.1186/s41927-018-0033-8. eCollection 2018.
3
Vitamin D deficiency is an etiological factor for MS - Commentary.维生素D缺乏是多发性硬化症的一个病因——评论。
Mult Scler. 2019 Apr;25(5):641-643. doi: 10.1177/1352458518815605. Epub 2018 Nov 30.
4
25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort.芬兰孕产妇队列中女性的25-羟基维生素D缺乏与多发性硬化症风险
Neurology. 2017 Oct 10;89(15):1578-1583. doi: 10.1212/WNL.0000000000004489. Epub 2017 Sep 13.
5
Adequate vitamin D levels in a Swedish population living above latitude 63°N: The 2009 Northern Sweden MONICA study.居住在北纬63°以北的瑞典人群的充足维生素D水平：2009年瑞典北部莫尼卡研究
Int J Circumpolar Health. 2015 Jan;74(1):27963. doi: 10.3402/ijch.v74.27963.
6
Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk.孟德尔随机化研究表明维生素 D 水平低与多发性硬化症风险之间存在因果关系。
Neurol Genet. 2016 Sep 13;2(5):e97. doi: 10.1212/NXG.0000000000000097. eCollection 2016 Oct.
7
Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study.维生素D与多发性硬化症风险：一项孟德尔随机化研究
PLoS Med. 2015 Aug 25;12(8):e1001866. doi: 10.1371/journal.pmed.1001866. eCollection 2015 Aug.
8
Vitamin D as a protective factor in multiple sclerosis.维生素 D 作为多发性硬化症的保护因素。
Neurology. 2012 Nov 20;79(21):2140-5. doi: 10.1212/WNL.0b013e3182752ea8.
9
Determining vitamin D status: a comparison between commercially available assays.测定维生素 D 状态：市售检测方法的比较。
PLoS One. 2010 Jul 13;5(7):e11555. doi: 10.1371/journal.pone.0011555.
10
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.血清25-羟基维生素D水平与多发性硬化症风险
JAMA. 2006 Dec 20;296(23):2832-8. doi: 10.1001/jama.296.23.2832.
Zotero 插件